TNSN05143A1 - CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - Google Patents

CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Info

Publication number
TNSN05143A1
TNSN05143A1 TNP2005000143A TNSN05143A TNSN05143A1 TN SN05143 A1 TNSN05143 A1 TN SN05143A1 TN P2005000143 A TNP2005000143 A TN P2005000143A TN SN05143 A TNSN05143 A TN SN05143A TN SN05143 A1 TNSN05143 A1 TN SN05143A1
Authority
TN
Tunisia
Prior art keywords
same
preparing
pharmaceutical compositions
compositions containing
strontium ranelate
Prior art date
Application number
TNP2005000143A
Other languages
French (fr)
Inventor
Horvath Stephane
Demuynck Isabelle
Damen Gerard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0410335A external-priority patent/FR2875807B1/en
Application filed by Servier Lab filed Critical Servier Lab
Priority to TNP2005000143A priority Critical patent/TNSN05143A1/en
Publication of TNSN05143A1 publication Critical patent/TNSN05143A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

FORME CRISTALLINE ALPHA DU RANELATE DE STRONTIUM, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT. FORME CRISTALLINE ALPHA DU RANELATE DE STRONTIUM DE FORMULE (I) : CARACTERISEE PAR SON DIAGRAMME DE DIFFRACTION X SUR POUDRE ET PAR UNE TENEUR EN EAU COMPRISE ENTRE 22 ET 24%. MEDICAMENTS.ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE OF FORMULA (I): CHARACTERIZED BY ITS X-DIFFRACTION DIAGRAM ON POWDER AND BY A WATER CONTENT OF BETWEEN 22 AND 24%. DRUGS.

TNP2005000143A 2004-09-30 2005-05-23 CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME TNSN05143A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP2005000143A TNSN05143A1 (en) 2004-09-30 2005-05-23 CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0410335A FR2875807B1 (en) 2004-09-30 2004-09-30 ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
TNP2005000143A TNSN05143A1 (en) 2004-09-30 2005-05-23 CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
TNSN05143A1 true TNSN05143A1 (en) 2007-05-14

Family

ID=59799126

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2005000143A TNSN05143A1 (en) 2004-09-30 2005-05-23 CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Country Status (1)

Country Link
TN (1) TNSN05143A1 (en)

Similar Documents

Publication Publication Date Title
MA27815A1 (en) ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
MA28133A1 (en) CRYSTALLINE FORM IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28450B1 (en) NOVEL IV CRYSTALLINE FORM OF AGOMELATIN, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28132A1 (en) GAMMAD CRYSTALLINE FORM IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
MA28451B1 (en) NOVEL CRYSTALLINE FORM V OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28134A1 (en) CRYSTALLINE GAMMA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
MA28449B1 (en) NOVEL CRYSTALLINE FORM III OF AGOMELATIN, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA30276B1 (en) ALPHA CRYSTALLINE FORM OF PERINOPRIL ARGININE SALT, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
CA2415442A1 (en) Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
CA2415438A1 (en) .alpha. crystalline form of perindopril tert-butylamine salt
FR2891827B1 (en) CRYSTALLINE DELTAD FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28626B1 (en) CRYSTALLINE DELTA FORM OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EA200700049A1 (en) PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL
SI1778680T1 (en) Spirocyclic cyclohexane derivatives
HRP20040107B1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
HRP20041092A2 (en) New pharmaceutical compositions containing filbanserin polymorph a
TR200102811T2 (en) Pharmaceutical preparation containing tolpersion for oral administration.
DE60041655D1 (en) TRIGGERING RECEPTOR INVOLVED IN NATURAL CYTOTOXICITY OF NATURAL KILLER CELLS AND ANTIBODIES IDENTIFYING THIS RECEPTOR
TW200517127A (en) Novel composition
TNSN05143A1 (en) CRYSTALLINE ALPHA FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
TNSN06309A1 (en) CRYSTALLINE FORM бd OF IVABRADINE HYDROCHLORIDE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28191A1 (en) NOVEL CRYSTALLINE FORM "ALPHA" OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
MA28192A1 (en) NOVEL β-CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
MA28189A1 (en) NOVEL CRYSTALLINE Y-FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRILL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME